在胃肠道中IL-17免疫调节的新出现的表现
Tiane Chen1, Jacqueline E Birkness-Gartman1, Tatianna C Larman1
1Department of Pathology, Division of Gastrointestinal and Liver Pathology, Johns Hopkins University, Baltimore, MD, USA.
Human pathology
|May 4, 2025
概括
互白素17 (IL-17) 抑制剂可以矛盾地在患者中引起新发性结肠炎,模仿炎症性肠病 (IBD). 治疗需要停止IL-17抑制剂,并开始IBD治疗以缓解症状.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 介素17 (IL-17) 是一种促炎性细胞因子,涉及到自身免疫性疾病.
- IL-17抑制剂对诸如牛皮和牛皮性关节炎等疾病有效.
- 矛盾的是,IL-17抑制剂与炎症性肠病 (IBD) 患者的新发性结肠炎有关.
研究的目的:
- 在使用IL-17抑制剂的患者中研究新发性结肠炎的临床和组织学特征.
- 了解IL-17抑制与胃肠道症状的发展之间的关系.
主要方法:
- 对活检档案的回顾性审查和查阅材料.
- 在使用IL-17抑制剂时,发现出现新发的胃肠道症状的患者.
- 患者队列的临床和组织学分析.
主要成果:
- 在IL-17抑制剂启动后,五名患者被确定患有新发血性腹.
- 内镜和组织学发现与炎症性肠病 (IBD) 一致.
- 四名患者在临床上被诊断患有IBD,需要停止IL-17抑制剂和启动IBD治疗.
结论:
- 在接受IL-17抑制剂的患者中,新发性结肠炎呈现出与IBD,原发性免疫缺陷和其他免疫调节疗法重叠的谱.
- 症状的解决需要IBD生物药物,这表明一个过程超出了自我限制的药物反应.
- 需要进一步的研究来确定IL-17抑制剂是否会揭露易感IBD或诱导新的IBD.
相关概念视频
T Cell Types and Functions
615
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
615
Inflammatory Bowel Disease I: Ulcerative Colitis
93
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
93
Inflammatory Bowel Disease II: Crohn's Disease
124
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
124
Chronic Bowel Disorders: Introduction
300
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
300
Irritable Bowel Syndrome I: Introduction
201
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
201
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K


